insights_auto
Why is TEM down 4.80%?
Dive Deeperchevron_right
TEM:BCBA
Tempus Ai Inc Cedear
ARS 9,120.00
arrow_downward
-4.80%(-460.00) 1D
Oct 13, 5:00:00 PM GMT-3 · ARS
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TEM...
Open
ARS 9,110.00
High
ARS 9,250.00
Low
ARS 8,905.00
Mkt. cap
12.31B
Avg. vol.
0.00
Volume
3.63K
52-wk high
ARS 12,360.00
52-wk low
ARS 5,165.00
Shares outstanding
175.39M
No. of employees
4K
Open
ARS 9,110.00
High
ARS 9,250.00
Low
ARS 8,905.00
Mkt. cap
12.31B
Avg. vol.
0.00
Volume
3.63K
52-wk high
ARS 12,360.00
52-wk low
ARS 5,165.00
Shares outstanding
175.39M
No. of employees
4K
News stories
From web sources and news partners
MarketBeat
·
1 hour ago
64,287 Shares in Tempus AI, Inc. $TEM Purchased by Fagan Associates Inc.
Simply Wall Street
·
17 hours ago
Is Expanded Cancer Therapy Collaboration Altering The Investment Case For Tempus AI (TEM)?
Traders Union
·
1 day ago
What's behind Tempus AI's latest stock pullback?
Yahoo Finance
·
1 day ago
Tempus AI Expands Strategic Collaborations to Drive Future Growth
Profile
Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM." Wikipedia
About Tempus Ai Inc Cedear
CEOEric Lefkofsky
Employees3.8K
Founded2015
HeadquartersChicago, Illinois, United States
SectorHealth care
Websitetempus.com